- 2024-08-20 01:54抑制剂Evacetrapib|Evacetrapib|1186486-62-3|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:54抑制剂EUK-134|EUK-134|81065-76-1|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:54抑制剂EUK-134|EUK-134|81065-76-1|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:54抑制剂EUK-134|EUK-134|81065-76-1|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:54抑制剂Et-29|Et-29|2166487-23-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:54抑制剂ETP-46321|ETP-46321|1252594-99-2|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:54抑制剂ETP-46321|ETP-46321|1252594-99-2|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:54抑制剂ETP-46321|ETP-46321|1252594-99-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:54抑制剂Estrogen receptor modulator 1|Estrogen receptor modulator 1|63676-22-2|Adamas life|≥98%（以实测数值为准）|
- 2024-08-20 01:54抑制剂Et-29|Et-29|2166487-23-4|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:54抑制剂Et-29|Et-29|2166487-23-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:54抑制剂ErSO|ErSO|2407860-35-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:54抑制剂ESI-09|ESI-09|263707-16-0|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 01:54抑制剂ESI-09|ESI-09|263707-16-0|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:54抑制剂ESI-09|ESI-09|263707-16-0|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:54抑制剂ERAP1-IN-1|ERAP1-IN-1|865273-97-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:54抑制剂ErSO|ErSO|2407860-35-7|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:54抑制剂ErSO|ErSO|2407860-35-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:54抑制剂ER proteostasis regulator-1|ER proteostasis regulator-1|912777-95-8|Adamas life|≥98%（以实测数值为准）|BR|
- 2024-08-20 01:54抑制剂ER proteostasis regulator-1|ER proteostasis regulator-1|912777-95-8|Adamas life|≥98%（以实测数值为准）|BR|
